Previous studies demonstrated that SSTR2 expression in a small cohort of rectal NETs (range 3–13 patients) and the majority of them were included as a component of left colon or colorectal NET cohorts18,38–41. The gene discussed is SSTR2; the disease is colorectal neuroendocrine tumor.